Simultaneous quantitation of zidovudine and zidovudine monophosphate from plasma, amniotic fluid and tissues by micellar capillary electrophoresis

Yazen Alnouti, Catherine A. White, Michael G. Bartlett

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Zidovudine (AZT) therapy given during pregnancy has been shown to reduce the vertical transmission of the human immunodeficiency virus (HIV) from mother to fetus. In order to investigate the efficacy of AZT, it is important to know the concentration of its active phosphorylated metabolites. We have developed the first CE method for the simultaneous quantitation of AZT and zidovudine monophosphate (AZT-MP) from rat plasma, amniotic fluid and fetal tissues. Sample extractions were performed by protein precipitation using acetonitrile for the plasma and amniotic fluids, while in fetal tissues solid phase extraction using Waters Oasis™ HLB extraction cartridges was used. Recoveries ranged from 78 to 92% for AZT, AZT-MP and 3′-azidouridine (internal standard, AZDU), in the three matrices. The optimum separation conditions were achieved using a 40 mM sodium dodecylsulfate (SDS) in 50 mM phosphate buffer (pH 7) with a run voltage of 15 kV. The CE system consists of a 75 μm i.d., 50 cm effective length uncoated fused silica capillary. The method was validated over the range 0.5-100 μ g/ml (μg/g for tissues). Intra-day precision (RSD) and accuracy (%error) for AZT ranged from 0.13 to 11 and 0.68 to 11.1%, respectively, while for AZT-MP it ranged from 2.05 to 11.1 and 4.22 to 11.7%. Inter-day precision and accuracy for AZT ranged from 3.82 to 11.2 and 3.14 to 9.01%, while for AZT-MP it ranged from 3.9 to 9.32 and 3.44 to 9.37%, respectively. We also report the enzymatic dephosphorylation of AZT-MP in the placental tissue of rats. This new enzymatic pathway provides increased understanding of the mechanism of anti-viral transport in the rat during pregnancy.

Original languageEnglish (US)
Pages (from-to)523-531
Number of pages9
JournalBiomedical Chromatography
Volume18
Issue number8
DOIs
StatePublished - Oct 1 2004

Fingerprint

Capillary electrophoresis
Zidovudine
Capillary Electrophoresis
Amniotic Fluid
Tissue
Plasmas
Fluids
Rats
Fetus
Pregnancy
Solid Phase Extraction
Fused silica
Metabolites
Viruses
Silicon Dioxide
Buffers
Sodium
Phosphates
HIV
Recovery

Keywords

  • Capillary electrophoresis
  • Enzymatic degradation
  • Validation
  • Zidovudine
  • Zidovudine monophosphate

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Simultaneous quantitation of zidovudine and zidovudine monophosphate from plasma, amniotic fluid and tissues by micellar capillary electrophoresis. / Alnouti, Yazen; White, Catherine A.; Bartlett, Michael G.

In: Biomedical Chromatography, Vol. 18, No. 8, 01.10.2004, p. 523-531.

Research output: Contribution to journalArticle

@article{94b077cf76684319a669154b08a83907,
title = "Simultaneous quantitation of zidovudine and zidovudine monophosphate from plasma, amniotic fluid and tissues by micellar capillary electrophoresis",
abstract = "Zidovudine (AZT) therapy given during pregnancy has been shown to reduce the vertical transmission of the human immunodeficiency virus (HIV) from mother to fetus. In order to investigate the efficacy of AZT, it is important to know the concentration of its active phosphorylated metabolites. We have developed the first CE method for the simultaneous quantitation of AZT and zidovudine monophosphate (AZT-MP) from rat plasma, amniotic fluid and fetal tissues. Sample extractions were performed by protein precipitation using acetonitrile for the plasma and amniotic fluids, while in fetal tissues solid phase extraction using Waters Oasis™ HLB extraction cartridges was used. Recoveries ranged from 78 to 92{\%} for AZT, AZT-MP and 3′-azidouridine (internal standard, AZDU), in the three matrices. The optimum separation conditions were achieved using a 40 mM sodium dodecylsulfate (SDS) in 50 mM phosphate buffer (pH 7) with a run voltage of 15 kV. The CE system consists of a 75 μm i.d., 50 cm effective length uncoated fused silica capillary. The method was validated over the range 0.5-100 μ g/ml (μg/g for tissues). Intra-day precision (RSD) and accuracy ({\%}error) for AZT ranged from 0.13 to 11 and 0.68 to 11.1{\%}, respectively, while for AZT-MP it ranged from 2.05 to 11.1 and 4.22 to 11.7{\%}. Inter-day precision and accuracy for AZT ranged from 3.82 to 11.2 and 3.14 to 9.01{\%}, while for AZT-MP it ranged from 3.9 to 9.32 and 3.44 to 9.37{\%}, respectively. We also report the enzymatic dephosphorylation of AZT-MP in the placental tissue of rats. This new enzymatic pathway provides increased understanding of the mechanism of anti-viral transport in the rat during pregnancy.",
keywords = "Capillary electrophoresis, Enzymatic degradation, Validation, Zidovudine, Zidovudine monophosphate",
author = "Yazen Alnouti and White, {Catherine A.} and Bartlett, {Michael G.}",
year = "2004",
month = "10",
day = "1",
doi = "10.1002/bmc.350",
language = "English (US)",
volume = "18",
pages = "523--531",
journal = "Biomedical Chromatography",
issn = "0269-3879",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Simultaneous quantitation of zidovudine and zidovudine monophosphate from plasma, amniotic fluid and tissues by micellar capillary electrophoresis

AU - Alnouti, Yazen

AU - White, Catherine A.

AU - Bartlett, Michael G.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Zidovudine (AZT) therapy given during pregnancy has been shown to reduce the vertical transmission of the human immunodeficiency virus (HIV) from mother to fetus. In order to investigate the efficacy of AZT, it is important to know the concentration of its active phosphorylated metabolites. We have developed the first CE method for the simultaneous quantitation of AZT and zidovudine monophosphate (AZT-MP) from rat plasma, amniotic fluid and fetal tissues. Sample extractions were performed by protein precipitation using acetonitrile for the plasma and amniotic fluids, while in fetal tissues solid phase extraction using Waters Oasis™ HLB extraction cartridges was used. Recoveries ranged from 78 to 92% for AZT, AZT-MP and 3′-azidouridine (internal standard, AZDU), in the three matrices. The optimum separation conditions were achieved using a 40 mM sodium dodecylsulfate (SDS) in 50 mM phosphate buffer (pH 7) with a run voltage of 15 kV. The CE system consists of a 75 μm i.d., 50 cm effective length uncoated fused silica capillary. The method was validated over the range 0.5-100 μ g/ml (μg/g for tissues). Intra-day precision (RSD) and accuracy (%error) for AZT ranged from 0.13 to 11 and 0.68 to 11.1%, respectively, while for AZT-MP it ranged from 2.05 to 11.1 and 4.22 to 11.7%. Inter-day precision and accuracy for AZT ranged from 3.82 to 11.2 and 3.14 to 9.01%, while for AZT-MP it ranged from 3.9 to 9.32 and 3.44 to 9.37%, respectively. We also report the enzymatic dephosphorylation of AZT-MP in the placental tissue of rats. This new enzymatic pathway provides increased understanding of the mechanism of anti-viral transport in the rat during pregnancy.

AB - Zidovudine (AZT) therapy given during pregnancy has been shown to reduce the vertical transmission of the human immunodeficiency virus (HIV) from mother to fetus. In order to investigate the efficacy of AZT, it is important to know the concentration of its active phosphorylated metabolites. We have developed the first CE method for the simultaneous quantitation of AZT and zidovudine monophosphate (AZT-MP) from rat plasma, amniotic fluid and fetal tissues. Sample extractions were performed by protein precipitation using acetonitrile for the plasma and amniotic fluids, while in fetal tissues solid phase extraction using Waters Oasis™ HLB extraction cartridges was used. Recoveries ranged from 78 to 92% for AZT, AZT-MP and 3′-azidouridine (internal standard, AZDU), in the three matrices. The optimum separation conditions were achieved using a 40 mM sodium dodecylsulfate (SDS) in 50 mM phosphate buffer (pH 7) with a run voltage of 15 kV. The CE system consists of a 75 μm i.d., 50 cm effective length uncoated fused silica capillary. The method was validated over the range 0.5-100 μ g/ml (μg/g for tissues). Intra-day precision (RSD) and accuracy (%error) for AZT ranged from 0.13 to 11 and 0.68 to 11.1%, respectively, while for AZT-MP it ranged from 2.05 to 11.1 and 4.22 to 11.7%. Inter-day precision and accuracy for AZT ranged from 3.82 to 11.2 and 3.14 to 9.01%, while for AZT-MP it ranged from 3.9 to 9.32 and 3.44 to 9.37%, respectively. We also report the enzymatic dephosphorylation of AZT-MP in the placental tissue of rats. This new enzymatic pathway provides increased understanding of the mechanism of anti-viral transport in the rat during pregnancy.

KW - Capillary electrophoresis

KW - Enzymatic degradation

KW - Validation

KW - Zidovudine

KW - Zidovudine monophosphate

UR - http://www.scopus.com/inward/record.url?scp=5044235809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5044235809&partnerID=8YFLogxK

U2 - 10.1002/bmc.350

DO - 10.1002/bmc.350

M3 - Article

C2 - 15386521

AN - SCOPUS:5044235809

VL - 18

SP - 523

EP - 531

JO - Biomedical Chromatography

JF - Biomedical Chromatography

SN - 0269-3879

IS - 8

ER -